Total Payments
$4,651
2024 Payments
$360.49
Companies
17
Transactions
91
Medicare Patients
3,250
Medicare Billing
$227,545
Payment Breakdown by Category
Food & Beverage$4,551 (97.9%)
Education$99.95 (2.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,551 | 90 | 97.9% |
| Education | $99.95 | 1 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $1,829 | 33 | $0 (2023) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $482.04 | 14 | $0 (2024) |
| CVRx, Inc. | $438.11 | 4 | $0 (2024) |
| Amgen Inc. | $378.90 | 4 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $347.02 | 3 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $273.42 | 14 | $0 (2024) |
| Medtronic, Inc. | $165.26 | 3 | $0 (2023) |
| Medtronic Vascular, Inc. | $139.11 | 3 | $0 (2020) |
| PFIZER INC. | $123.48 | 2 | $0 (2022) |
| Relypsa, Inc. | $122.31 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $360.49 | 8 | AstraZeneca Pharmaceuticals LP ($122.09) |
| 2023 | $377.08 | 11 | Medtronic, Inc. ($140.73) |
| 2022 | $827.93 | 17 | CVRx, Inc. ($380.99) |
| 2021 | $200.89 | 5 | Amgen Inc. ($122.11) |
| 2020 | $157.20 | 4 | Abbott Laboratories ($85.46) |
| 2019 | $900.54 | 18 | Abbott Laboratories ($278.80) |
| 2018 | $1,605 | 26 | Abbott Laboratories ($1,115) |
| 2017 | $221.79 | 2 | Relypsa, Inc. ($122.31) |
All Payment Transactions
91 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $48.92 | General |
| 11/07/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $54.75 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 11/04/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/25/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $57.12 | General |
| Category: Heart Failure and Hypertension | ||||||
| 09/23/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/17/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: Cardiology | ||||||
| 04/29/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $27.62 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 03/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $122.09 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/16/2023 | Abbott Laboratories | AMPLATZER AMULET (Device) | Food and Beverage | In-kind items and services | $62.20 | General |
| Category: Structural Heart | ||||||
| 05/24/2023 | Medtronic, Inc. | COREVALVE EVOLUT R (Device) | Food and Beverage | In-kind items and services | $28.94 | General |
| Category: Transcatheter Valve Systems | ||||||
| 05/08/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/03/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/08/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/04/2023 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $44.55 | General |
| Category: WATCHMAN_IC | ||||||
| 02/27/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/15/2023 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $111.79 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 02/13/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/09/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $19.72 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 01/11/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/21/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/23/2022 | Abbott Laboratories | CONFIRM RX (Device) | Food and Beverage | In-kind items and services | $25.30 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/23/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/23/2022 | Abbott Laboratories | CONFIRM RX (Device) | Food and Beverage | In-kind items and services | $2.61 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/15/2022 | Medtronic, Inc. | MICRA (Device) | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: Pacemakers | ||||||
| 11/09/2022 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $108.28 | General |
| Category: Heart Failure and Hypertension | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 819 | 916 | $123,253 | $36,360 |
| 2022 | 18 | 1,165 | 1,573 | $330,413 | $95,034 |
| 2021 | 19 | 1,044 | 1,290 | $205,938 | $79,786 |
| 2020 | 9 | 222 | 247 | $36,830 | $16,365 |
Total Patients
3,250
Total Services
4,026
Medicare Billing
$227,545
Procedure Codes
67
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 72 | 72 | $36,720 | $8,277 | 22.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 146 | 147 | $26,642 | $7,766 | 29.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 63 | 67 | $10,750 | $5,563 | 51.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 32 | 70 | $9,786 | $4,276 | 43.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 22 | 22 | $5,080 | $2,216 | 43.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 243 | 292 | $9,799 | $1,775 | 18.1% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 18 | 18 | $6,000 | $1,476 | 24.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $3,202 | $1,394 | 43.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 23 | 23 | $2,992 | $1,198 | 40.0% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 12 | 17 | $1,392 | $646.25 | 46.4% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 39 | 39 | $2,506 | $411.18 | 16.4% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 20 | 20 | $1,690 | $366.24 | 21.7% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 18 | 18 | $1,332 | $276.35 | 20.7% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 15 | 15 | $1,241 | $193.26 | 15.6% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Facility | 2023 | 12 | 12 | $852.00 | $168.60 | 19.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 15 | 15 | $838.00 | $162.94 | 19.4% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 21 | 21 | $897.00 | $109.60 | 12.2% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 37 | 37 | $1,534 | $83.58 | 5.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 250 | 264 | $134,640 | $40,023 | 29.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 109 | 130 | $19,500 | $11,136 | 57.1% |
| Q9957 | Injection, perflutren lipid microspheres, per ml | Office | 2022 | 85 | 180 | $81,558 | $6,191 | 7.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 29 | 29 | $9,135 | $4,780 | 52.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 26 | 28 | $6,860 | $4,048 | 59.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 67 | 69 | $8,556 | $3,932 | 46.0% |
| 93798 | Outpatient heart rehabilitation with electrocardiogram (ecg) monitoring, quality health care professional services | Office | 2022 | 26 | 196 | $13,720 | $3,866 | 28.2% |
About Stephanie Windish
Stephanie Windish is a Cardiovascular Disease healthcare provider based in Olathe, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/10/2014. The National Provider Identifier (NPI) number assigned to this provider is 1912313883.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Stephanie Windish has received a total of $4,651 in payments from pharmaceutical and medical device companies, with $360.49 received in 2024. These payments were reported across 91 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($4,551).
As a Medicare-enrolled provider, Windish has provided services to 3,250 Medicare beneficiaries, totaling 4,026 services with total Medicare billing of $227,545. Data is available for 4 years (2020–2023), covering 67 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Olathe, KS
- Active Since 07/10/2014
- Last Updated 09/18/2024
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1912313883
Products in Payments
- LifeVest (Device) $482.04
- Barostim Neo System (Device) $438.11
- Merlin Connectivity and Remote (Device) $387.36
- Repatha (Biological) $378.90
- Confirm Rx (Device) $269.47
- BRILINTA (Drug) $224.93
- Assurity Pacemaker (Device) $217.81
- No Associated Product (Device) $173.43
- Quadra Assura CRT Defibrillator (Device) $162.97
- Micra (Device) $139.11
- CARDIOMEMS (Device) $124.02
- Veltassa (Drug) $122.31
- FARXIGA (Drug) $122.09
- Fortify Assura, Ellipse ICD (Device) $116.45
- AMPLATZER (Device) $115.03
- ENTRESTO (Drug) $113.31
- LINQ II (Device) $111.79
- LEQVIO (Drug) $111.19
- TandemLife (Device) $87.78
- ELIQUIS (Drug) $85.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Olathe
Rangarao Tummala, Md, MD
Cardiovascular Disease — Payments: $21,184
Cardiovascular Disease $21,184
Dr. Ravi Yarlagadda, M.d, M.D
Cardiovascular Disease — Payments: $13,362
Cardiovascular Disease $13,362
Dr. Sagar Vadhar, D.o, D.O
Cardiovascular Disease — Payments: $9,038
Cardiovascular Disease $9,038
Dr. Dusan Stanojevic, M.d, M.D
Cardiovascular Disease — Payments: $8,109
Cardiovascular Disease $8,109
Thomas Baldwin, Md, MD
Cardiovascular Disease — Payments: $7,751
Cardiovascular Disease $7,751
Dr. Ashutosh Bapat, Md, MD
Cardiovascular Disease — Payments: $6,567
Cardiovascular Disease $6,567